HomeHealthTailored cancer drug curbs melanoma recurrence in trial

Tailored cancer drug curbs melanoma recurrence in trial

Published on

spot_img


Employees train to be cell therapy specialists at Gilead unit Kite’s manufacturing facility in Frederick Maryland, US, March 14, 2024. — Reuters

US drugmakers Merck and Moderna said on Wednesday an experimental melanoma drug that delivers treatment tailored to a patient’s…

Latest articles

More like this